Depemokimab Compared with Mepolizumab for Patients with EGPA on Standard of Care Therapy: OCEAN

Study Findings: Study results are pending

ClinicalTrials.gov ID: NCT05263934

Study Dates: 2023-2025

Disease(s): Eosinophilic Granulomatosis with Polyangiitis (EGPA)